Related Experiment Videos
Pharmacokinetics of intravenous amoxicillin in pediatric patients
Antimicrobial Agents and Chemotherapy
|April 1, 1979
Insights
Intravenous amoxicillin dosing in children showed that higher doses led to proportionally higher peak serum levels. However, the drug's serum half-life remained consistent across different dosages in this pharmacokinetic study.
Area of Science:
- Pediatric Pharmacology
- Drug Metabolism and Pharmacokinetics
Background:
- Amoxicillin is a widely used antibiotic in pediatric populations.
- Understanding the pharmacokinetic profile of amoxicillin is crucial for optimizing pediatric dosing regimens.
Purpose of the Study:
- To determine the pharmacokinetic parameters of intravenous amoxicillin in infants and children.
- To investigate the relationship between amoxicillin dose and its peak serum concentrations and half-life in pediatric patients.
Main Methods:
- Pharmacokinetic analysis was performed on 14 pediatric subjects.
- Subjects received varying doses of intravenous amoxicillin.
- Serum samples were collected to measure amoxicillin concentrations over time.
Main Results:
- Peak serum amoxicillin concentrations increased in direct proportion to the administered dose.
- The serum half-life of amoxicillin was found to be consistent across the three different dose groups studied.
- Individual pharmacokinetic variability was observed within the pediatric population.
Conclusions:
- Intravenous amoxicillin exhibits dose-proportional pharmacokinetics regarding peak serum levels in pediatric patients.
- The elimination half-life of amoxicillin appears independent of dose in this age group.
- These findings support the potential for dose adjustments to achieve target therapeutic concentrations in pediatric infections.
Abstract:
Pharmacokinetic parameters were obtained from 14 infants and children receiving intravenous amoxicillin. Peak serum values increased proportionally to the increase in dose; the serum half-life was similar in the three dose groups studied.